comparemela.com

Rheinische Friedrich Wilhelm University News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SCAI bestows highest designation ranking to lead

 E-Mail WASHINGTON - The Society for Cardiovascular Angiography and Interventions (SCAI) presented its Master Interventionalists of SCAI (MSCAI) designations during the SCAI 2020 Scientific Sessions Virtual Conference MSCAI recognition ceremony. The MSCAI designation is awarded to individuals who have demonstrated excellence in invasive/interventional cardiology over the course of their career and for their commitment to the highest levels of clinical care, innovation, publication, and teaching. This year s MSCAI designations were awarded to the following group of outstanding interventionalists: Ian C. Gilchrist, MD, MSCAI Dr. Ian C. Gilchrist is a professor of medicine for Penn State University s College of Medicine at the Hershey Medical Center in Hershey, PA. Dr. Gilchrist graduated from Dartmouth College in Hanover, NH and then obtained his medical degree from Columbia University. He received his residency and cardiology fellowship training at the St. Luke s/Roosevelt Hosp

Society for Cardiovascular Angiography and Interventions bestows highest designation ranking to lead

 E-Mail WASHINGTON - The Society for Cardiovascular Angiography and Interventions (SCAI) presented its Master Interventionalists of SCAI (MSCAI) designations during the SCAI 2020 Scientific Sessions Virtual Conference MSCAI recognition ceremony. The MSCAI designation is awarded to individuals who have demonstrated excellence in invasive/interventional cardiology over the course of their career and for their commitment to the highest levels of clinical care, innovation, publication, and teaching. This year s MSCAI designations were awarded to the following group of outstanding interventionalists: Ian C. Gilchrist, MD, MSCAI Dr. Ian C. Gilchrist is a professor of medicine for Penn State University s College of Medicine at the Hershey Medical Center in Hershey, PA. Dr. Gilchrist graduated from Dartmouth College in Hanover, NH and then obtained his medical degree from Columbia University. He received his residency and cardiology fellowship training at the St. Luke s/Roosevelt Hospi

Kite Appoints Frank Neumann as Worldwide Head of Clinical Development

Kite Appoints Frank Neumann as Worldwide Head of Clinical Development Industry Leader in Cell Therapy and Oncology Drug Development Positioned for Continued Advancement of Kite’s Clinical Programs Kite, a Gilead Company today announced that Frank Neumann, MD, PhD, has joined the company as Senior Vice President and Global Head of Clinical Development. Dr. Neumann will lead Kite’s Clinical Development organization across hematological malignancies and solid tumors. Ken … Industry Leader in Cell Therapy and Oncology Drug Development Positioned for Continued Advancement of Kite’s Clinical Programs Kite, a Gilead Company (Nasdaq: GILD), today announced that Frank Neumann, MD, PhD, has joined the company as Senior Vice President and Global Head of Clinical Development. Dr. Neumann will lead Kite’s Clinical Development organization across hematological malignancies and solid tumors. Ken Takeshita, MD, has decided to leave the company to pursue another opportunity at t

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.